Developer docs
API playgroundTry for free, no card

Search company profiles

Atlanpole Biotherapies

Full company profile

uuid00299oa

Namestring
Atlanpole Biotherapies
Legal namestring
Atlanpole Biotherapies
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Atlanpole Biotherapies is a French non-profit cluster organization (association loi 1901) governed under the umbrella of GIP ATLANPOLE (Syndicat Mixte Atlanpole), a public interest group. Founded in 2005 and headquartered at Château de la Chantrerie in Nantes, the cluster coordinates health-innovation activity across three French regions — Pays de la Loire, Bretagne, and Centre-Val de Loire — serving a network of more than 200 members that includes roughly 150 companies, 30 research organizations, and 25 economic development structures. Its members span biotech and bioproduction, pharma, MedTech, Digital Health (e.g., Isidoctor, Orikio), and Disease Prevention, with member logos ranging from early-stage startups (Biodyssey, CXS Therapeutics, SPyDiag, Perha Pharmaceuticals, Xenothera, Procope Medicals) to commercial-stage enterprises (Valneva, Laboratoires Brothier) and large public institutions (CHU Nantes).

The cluster delivers four core services rather than technology products: Diversify Your Network (workshops, themed day meetings, conferences, partner introductions), Broaden Your Horizons (international congress access, EU-network inter-clustering, funding pathways), Develop Your Innovation Projects (feasibility studies, partner identification, project filing, cluster labeling), and Enhance Your Public Profile (monthly French newsletter, website, press releases, LinkedIn). Its distribution model relies on direct engagement with members, the Atlanpole partner-club referral channel, and participation in European inter-cluster projects including CE4BIG (with BioM, BioWin, Life Science Krakow), CEBR, Boost4Health, Atlantic Ket Med, and the upcoming MEDI4Future Interreg project scheduled for April 2026.

The revenue and funding model is non-commercial: Atlanpole Biotherapies is financed through public sources including Région Bretagne, Région Pays de la Loire, Région Centre-Val de Loire, French national government, and EU program grants (e.g., a €3M European grant within the €5M Boost4Health consortium). Pricing for cluster membership and services is not publicly disclosed. The organization operates with a small team of 11-50 employees led by Director Florence Hallouin, with Elodie Girardet managing European projects and Simon Boisserpe serving as Data Protection Officer. No venture capital, private equity, or external investment ownership is indicated, consistent with its status as a publicly funded competitiveness cluster ("pôle de compétitivité").

Short descriptiontext

Atlanpole Biotherapies is a French non-profit biocluster based in Nantes that connects 200-plus biotech, pharma, MedTech, digital health, and disease-prevention members across Pays de la Loire, Bretagne, and Centre-Val de Loire, delivering networking, innovation-project support, international expansion, and visibility services funded by regional councils and EU programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaint-germain-de-la-grange, France
HQ citystring
Saint-germain-de-la-grange
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotechnology cluster services, health innovation network, MedTech partnership support, digital health ecosystem, life sciences cluster
Industry2 codes
PRIMARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYEUAIANAH
Circularity Consulting & Program Management (EPR, Design-for-Circularity, LCA)
Energy, Utilities & Environment/Environmental Services (Waste Management, Recycling & Remediation)/Resource Recovery & Circular Economy Services (Reuse, Take-back, Refurbishment)
SIC code1 code
  • Services-Membership Organizations8600
Product category
Biotechnology Cluster Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cluster membership services
TypeOthers
Description

Atlanpole Biotherapies operates as a non-profit organization providing cluster services to members including networking, innovation project support, international expansion, and visibility enhancement. The organization is funded through public sources including regional councils (Région Bretagne, Région Pays de la Loire, Région Centre-Val de Loire) and European programs.

atlanpolebiotherapies.eu
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Atlanpole Biotherapies is a French non-profit biocluster that delivers four core cluster services to biotech, pharma, MedTech, and digital health organizations across the Pays de la Loire, Bretagne, and Centre-Val de Loire regions: network diversification through cluster events and meetings, international expansion support via congresses and European networks, innovation project development assistance including feasibility studies and partner matching, and public profile enhancement through newsletters, press releases, and digital channels. The organization operates as an association governed by the French Act of 1901 under the umbrella of GIP ATLANPOLE.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Atlanpole Biotherapies operates as a multi-service cluster platform rather than a traditional product company. It provides four interconnected core services: (1) Diversify your network, enabling members to boost business and develop collaborations through cluster events; (2) Broaden your horizons, offering international access to congresses, forums, and funding; (3) Develop your innovation projects, providing personalized support for biotech/health tech projects from feasibility to labeling; and (4) Enhance your public profile, promoting members through newsletters, website, press releases, and social media. The organization also maintains a network of over 200 members including companies, research organizations, and economic development structures across biotherapies, MedTech, Digital Health, and Disease Prevention sectors.

Product and service4 records
1Diversify your network
CategoryCore service
Description

A cluster service enabling members to boost their business and develop new collaborations by joining the network, participating in workshops, themed day meetings, conferences, and pharmaceutical industry meetings. Targeted at biotech, pharma, MedTech, and digital health member organizations.

2Broaden your horizons
CategoryCore service
Description

International expansion support service providing members access to international congresses and forums, the cluster's international network, and specific funding opportunities for internationalization.

3Develop your innovation projects
CategoryCore service
Description

Personalized support for innovation projects in biotechnology or health technology sectors, including feasibility studies, partner identification, project filing, and cluster labeling. Targeted at entrepreneurs, researchers, clinicians, and pharmaceutical industry professionals.

4Enhance your public profile
CategoryCore service
Description

Visibility and promotion service that relays member news through a monthly French newsletter, dedicated website, press releases, and social networks including LinkedIn to enhance the public profile of cluster members.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
1MEDI4Future
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Interreg North-West Europe project (2026-04 launch) focused on reducing waste in MedTech sector and promoting circular solutions. 11 partners from 6 European countries targeting 2.5 million tonnes annual healthcare waste reduction.

atlanpolebiotherapies.eu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-02-01
Description

Membership-driven network of lifescience clusters across Europe with approximately 40 subscription members. CEBR objectives include improving cluster support, reducing fragmentation, and transforming competitiveness into cooperation between regions.

3CE4BIG Consortium (Cluster Excellence for Business Innovation and Growth)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-02-01
Description

EU COSME funded project with four European healthcare clusters: Atlanpole Biotherapies (France), BioM (Germany), BioWin (Belgium), Life Science Krakow (Poland). Focuses on personalized medicine and SME support through ClusterXchange scheme.

atlanpolebiotherapies.eu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

European INTERREG project for SMEs providing access to services, expert networks, and partners in Germany, Denmark, Netherlands, UK, Belgium, and Spain. €5M total budget with €3M European grant. Distributed €53,000 to cluster SMEs, coached 8 companies to pitch in English.

Strategic tierCoreTypeOthers
Description

Parent organization (Syndicat Mixte Atlanpole) providing umbrella structure for Atlanpole Biotherapies and Atlanpole Entreprises entities. Located at Château de la Chantrerie, 95 route de Gachet, BP 90702, 44300 Nantes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regional biotechnology and healthcare sector structuring organization supporting innovative project leaders through consulting, partner matchmaking, project engineering, and access to funding.

7Région Bretagne
Strategic tierCoreTypeOthers
Description

Regional council providing public funding and support for the cluster's activities in Brittany region.

atlanpolebiotherapies.eu
Strategic tierCoreTypeOthers
Description

Regional council providing public funding and support for the cluster's activities in Pays de la Loire region where the cluster is primarily based.

9Région Centre-Val de Loire
Strategic tierMinorTypeOthers
Description

Regional council providing public funding and support for the cluster's activities in Centre-Val de Loire region.

atlanpolebiotherapies.eu
Strategic tierMinorTypeStrategic or Co-development Partner
Description

German health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Belgian health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.

12Life Science Krakow (Poland)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Polish health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.

atlanpolebiotherapies.eu
13Atlantic Ket Med
Strategic tierMinorTypeStrategic or Co-development Partner
Description

European project run by Galway University (Ireland), financed by Northern-West Europe Interreg. Brings new high-tech pilot production capacity for KETs-based medical devices to EU Atlantic Area.

atlanpolebiotherapies.eu
14Les pôles de compétitivité
Strategic tierCoreTypeStrategic or Co-development Partner
Description

French competitiveness clusters organization providing label and framework for the cluster network.

atlanpolebiotherapies.eu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Network of ~40 European life science clusters of which Atlanpole is a member; comparable organizational form (cluster association) operating one level up as a meta-network rather than as a regional cluster.

TypeDirect peer
Description

Belgian health and biotech competitiveness cluster (Wallonia) and CE4BIG partner, focused on advanced therapies and personalized medicine; near-identical cluster mandate serving SMEs, research institutes, and academic hospitals.

TypeDirect peer
Description

French competitiveness cluster covering PACA, Occitanie, and Corsica focused on diagnostics, therapeutics, and MedTech — directly overlaps with Atlanpole's biotech/pharma/MedTech focus within the same national ecosystem.

4Lyonbiopôle
TypeDirect peer
Description

French Auvergne-Rhône-Alpes competitiveness cluster for health technologies (biotech, MedTech, digital health); comparable service pillars in networking, innovation funding, and internationalization for health SMEs.

5Inserm Transfert
TypeEmerging player
Description

French technology transfer office of Inserm (public biomedical research), providing partnership, licensing, and SME creation services — overlapping with Atlanpole's biotech innovation support mandate at the academic/research interface.

TypeDirect peer
Description

German biotech cluster (Munich/Bavaria) and CE4BIG partner, offering network, funding access, and internationalization services to biotech SMEs — directly comparable mandate and member base to Atlanpole Biotherapies.

7Life Science Krakow Cluster
TypeDirect peer
Description

Polish life sciences cluster and CE4BIG partner with ESCA Silver Label; comparable services in networking, innovation project support, and internationalization for life science SMEs.

TypeBroad incumbent
Description

Larger French competitiveness cluster covering Île-de-France health innovation ecosystem; broader geographic scope and deeper pharma industry access make it a broader incumbent in the same national cluster landscape.

TypeDirect peer
Description

Regional biotech/health sector structuring organization in Brittany, providing consulting, partner matchmaking, and funding access — a regional French peer with overlapping service model.

TypeOthers
Description

Sister association under the same GIP ATLANPOLE umbrella providing broader technology/SME cluster services; an enabling peer sharing the same parent entity and overlapping member base in the Pays de la Loire ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Atlanpole Biotherapies

Biotechnology Cluster Servicesatlanpolebiotherapies.eu

Atlanpole Biotherapies is a French non-profit biocluster based in Nantes that connects 200-plus biotech, pharma, MedTech, digital health, and disease-prevention members across Pays de la Loire, Bretagne, and Centre-Val de Loire, delivering networking, innovation-project support, international expansion, and visibility services funded by regional councils and EU programs.

What Atlanpole Biotherapies does

Atlanpole Biotherapies is a French non-profit cluster organization (association loi 1901) governed under the umbrella of GIP ATLANPOLE (Syndicat Mixte Atlanpole), a public interest group. Founded in 2005 and headquartered at Château de la Chantrerie in Nantes, the cluster coordinates health-innovation activity across three French regions — Pays de la Loire, Bretagne, and Centre-Val de Loire — serving a network of more than 200 members that includes roughly 150 companies, 30 research organizations, and 25 economic development structures. Its members span biotech and bioproduction, pharma, MedTech, Digital Health (e.g., Isidoctor, Orikio), and Disease Prevention, with member logos ranging from early-stage startups (Biodyssey, CXS Therapeutics, SPyDiag, Perha Pharmaceuticals, Xenothera, Procope Medicals) to commercial-stage enterprises (Valneva, Laboratoires Brothier) and large public institutions (CHU Nantes).

The cluster delivers four core services rather than technology products: Diversify Your Network (workshops, themed day meetings, conferences, partner introductions), Broaden Your Horizons (international congress access, EU-network inter-clustering, funding pathways), Develop Your Innovation Projects (feasibility studies, partner identification, project filing, cluster labeling), and Enhance Your Public Profile (monthly French newsletter, website, press releases, LinkedIn). Its distribution model relies on direct engagement with members, the Atlanpole partner-club referral channel, and participation in European inter-cluster projects including CE4BIG (with BioM, BioWin, Life Science Krakow), CEBR, Boost4Health, Atlantic Ket Med, and the upcoming MEDI4Future Interreg project scheduled for April 2026.

The revenue and funding model is non-commercial: Atlanpole Biotherapies is financed through public sources including Région Bretagne, Région Pays de la Loire, Région Centre-Val de Loire, French national government, and EU program grants (e.g., a €3M European grant within the €5M Boost4Health consortium). Pricing for cluster membership and services is not publicly disclosed. The organization operates with a small team of 11-50 employees led by Director Florence Hallouin, with Elodie Girardet managing European projects and Simon Boisserpe serving as Data Protection Officer. No venture capital, private equity, or external investment ownership is indicated, consistent with its status as a publicly funded competitiveness cluster ("pôle de compétitivité").

Atlanpole Biotherapies firmographics

Firmographics
Name
Atlanpole Biotherapies
Legal name
Atlanpole Biotherapies
Website
https://atlanpolebiotherapies.eu
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
Atlanpole Biotherapies is a French non-profit biocluster based in Nantes that connects 200-plus biotech, pharma, MedTech, digital health, and disease-prevention members across Pays de la Loire, Bretagne, and Centre-Val de Loire, delivering networking, innovation-project support, international expansion, and visibility services funded by regional councils and EU programs.
Ownership category
akta.pro rank

Atlanpole Biotherapies industry classification

Industry
Product category
Biotechnology Cluster Services
SIC
Services-Membership Organizations (8600)
akta.pro industry
PRIMARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYEUAIANAH
Circularity Consulting & Program Management (EPR, Design-for-Circularity, LCA)
Energy, Utilities & Environment/Environmental Services (Waste Management, Recycling & Remediation)/Resource Recovery & Circular Economy Services (Reuse, Take-back, Refurbishment)

Keywords

  • Biotechnology cluster services
  • Health innovation network
  • MedTech partnership support
  • Digital health ecosystem
  • Life sciences cluster

Where Atlanpole Biotherapies is headquartered

Location

Headquarters

HQ city
Saint-germain-de-la-grange
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Atlanpole Biotherapies business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Cluster membership services: Atlanpole Biotherapies operates as a non-profit organization providing cluster services to members including networking, innovation project support, international expansion, and visibility enhancement. The organization is funded through public sources including regional councils (Région Bretagne, Région Pays de la Loire, Région Centre-Val de Loire) and European programs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Atlanpole Biotherapies product offering

Product offering

Core offering

Atlanpole Biotherapies is a French non-profit biocluster that delivers four core cluster services to biotech, pharma, MedTech, and digital health organizations across the Pays de la Loire, Bretagne, and Centre-Val de Loire regions: network diversification through cluster events and meetings, international expansion support via congresses and European networks, innovation project development assistance including feasibility studies and partner matching, and public profile enhancement through newsletters, press releases, and digital channels. The organization operates as an association governed by the French Act of 1901 under the umbrella of GIP ATLANPOLE.

Product overview

Atlanpole Biotherapies operates as a multi-service cluster platform rather than a traditional product company. It provides four interconnected core services: (1) Diversify your network, enabling members to boost business and develop collaborations through cluster events; (2) Broaden your horizons, offering international access to congresses, forums, and funding; (3) Develop your innovation projects, providing personalized support for biotech/health tech projects from feasibility to labeling; and (4) Enhance your public profile, promoting members through newsletters, website, press releases, and social media. The organization also maintains a network of over 200 members including companies, research organizations, and economic development structures across biotherapies, MedTech, Digital Health, and Disease Prevention sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Diversify your network A cluster service enabling members to boost their business and develop new collaborations by joining the network, participating in workshops, themed day meetings, conferences, and pharmaceutical industry meetings. Targeted at biotech, pharma, MedTech, and digital health member organizations.
  • Broaden your horizons International expansion support service providing members access to international congresses and forums, the cluster's international network, and specific funding opportunities for internationalization.
  • Develop your innovation projects Personalized support for innovation projects in biotechnology or health technology sectors, including feasibility studies, partner identification, project filing, and cluster labeling. Targeted at entrepreneurs, researchers, clinicians, and pharmaceutical industry professionals.
  • Enhance your public profile Visibility and promotion service that relays member news through a monthly French newsletter, dedicated website, press releases, and social networks including LinkedIn to enhance the public profile of cluster members.

Companies that use Atlanpole Biotherapies

Customer profile

Named customers12 records

Segments6 records

Ideal customer profiles4 records

Atlanpole Biotherapies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Atlanpole Biotherapies partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered minor and core.

  • MEDI4FutureminorStrategic or Co-development Partner · 1 April 2026Interreg North-West Europe project (2026-04 launch) focused on reducing waste in MedTech sector and promoting circular solutions. 11 partners from 6 European countries targeting 2.5 million tonnes annual healthcare waste reduction.
  • CEBR (Council of European Bioregions)coreStrategic or Co-development Partner · 1 February 2020Membership-driven network of lifescience clusters across Europe with approximately 40 subscription members. CEBR objectives include improving cluster support, reducing fragmentation, and transforming competitiveness into cooperation between regions.
  • CE4BIG Consortium (Cluster Excellence for Business Innovation and Growth)coreStrategic or Co-development Partner · 1 February 2020EU COSME funded project with four European healthcare clusters: Atlanpole Biotherapies (France), BioM (Germany), BioWin (Belgium), Life Science Krakow (Poland). Focuses on personalized medicine and SME support through ClusterXchange scheme.
  • Boost4HealthcoreStrategic or Co-development Partner · 1 January 2016European INTERREG project for SMEs providing access to services, expert networks, and partners in Germany, Denmark, Netherlands, UK, Belgium, and Spain. €5M total budget with €3M European grant. Distributed €53,000 to cluster SMEs, coached 8 companies to pitch in English.
  • AtlanpolecoreOthersParent organization (Syndicat Mixte Atlanpole) providing umbrella structure for Atlanpole Biotherapies and Atlanpole Entreprises entities. Located at Château de la Chantrerie, 95 route de Gachet, BP 90702, 44300 Nantes.
  • Biotech Santé BretagnecoreStrategic or Co-development PartnerRegional biotechnology and healthcare sector structuring organization supporting innovative project leaders through consulting, partner matchmaking, project engineering, and access to funding.
  • Région BretagnecoreOthersRegional council providing public funding and support for the cluster's activities in Brittany region.
  • Région Pays de la LoirecoreOthersRegional council providing public funding and support for the cluster's activities in Pays de la Loire region where the cluster is primarily based.
  • Région Centre-Val de LoireminorOthersRegional council providing public funding and support for the cluster's activities in Centre-Val de Loire region.
  • BioM (Germany)minorStrategic or Co-development PartnerGerman health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.
  • BioWin (Belgium)minorStrategic or Co-development PartnerBelgian health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.
  • Life Science Krakow (Poland)minorStrategic or Co-development PartnerPolish health cluster partner in CE4BIG consortium, focused on advanced therapies for personalized medicine.
  • Atlantic Ket MedminorStrategic or Co-development PartnerEuropean project run by Galway University (Ireland), financed by Northern-West Europe Interreg. Brings new high-tech pilot production capacity for KETs-based medical devices to EU Atlantic Area.
  • Les pôles de compétitivitécoreStrategic or Co-development PartnerFrench competitiveness clusters organization providing label and framework for the cluster network.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Atlanpole Biotherapies competitors and assessment

Company assessment

Others

  • Council of European Bioregions (CEBR): Network of ~40 European life science clusters of which Atlanpole is a member; comparable organizational form (cluster association) operating one level up as a meta-network rather than as a regional cluster.
  • Atlanpole Entreprises: Sister association under the same GIP ATLANPOLE umbrella providing broader technology/SME cluster services; an enabling peer sharing the same parent entity and overlapping member base in the Pays de la Loire ecosystem.

Direct peers

  • BioWin: Belgian health and biotech competitiveness cluster (Wallonia) and CE4BIG partner, focused on advanced therapies and personalized medicine; near-identical cluster mandate serving SMEs, research institutes, and academic hospitals.
  • Eurobiomed: French competitiveness cluster covering PACA, Occitanie, and Corsica focused on diagnostics, therapeutics, and MedTech — directly overlaps with Atlanpole's biotech/pharma/MedTech focus within the same national ecosystem.
  • Lyonbiopôle: French Auvergne-Rhône-Alpes competitiveness cluster for health technologies (biotech, MedTech, digital health); comparable service pillars in networking, innovation funding, and internationalization for health SMEs.
  • BioM: German biotech cluster (Munich/Bavaria) and CE4BIG partner, offering network, funding access, and internationalization services to biotech SMEs — directly comparable mandate and member base to Atlanpole Biotherapies.
  • Life Science Krakow Cluster: Polish life sciences cluster and CE4BIG partner with ESCA Silver Label; comparable services in networking, innovation project support, and internationalization for life science SMEs.
  • Biotech Santé Bretagne: Regional biotech/health sector structuring organization in Brittany, providing consulting, partner matchmaking, and funding access — a regional French peer with overlapping service model.

Emerging players

  • Inserm Transfert: French technology transfer office of Inserm (public biomedical research), providing partnership, licensing, and SME creation services — overlapping with Atlanpole's biotech innovation support mandate at the academic/research interface.

Broad incumbents

  • Medicen Paris Region: Larger French competitiveness cluster covering Île-de-France health innovation ecosystem; broader geographic scope and deeper pharma industry access make it a broader incumbent in the same national cluster landscape.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Atlanpole Biotherapies social profiles

Digital presence

Atlanpole Biotherapies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Atlanpole Biotherapies leadership team

Management profile

Number of profiles

Profiles3 records

Atlanpole Biotherapies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Atlanpole Biotherapies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlanpole Biotherapies

What does Atlanpole Biotherapies do?

Atlanpole Biotherapies is a French non-profit biocluster that delivers four core cluster services to biotech, pharma, MedTech, and digital health organizations across the Pays de la Loire, Bretagne, and Centre-Val de Loire regions: network diversification through cluster events and meetings, international expansion support via congresses and European networks, innovation project development assistance including feasibility studies and partner matching, and public profile enhancement through newsletters, press releases, and digital channels. The organization operates as an association governed by the French Act of 1901 under the umbrella of GIP ATLANPOLE.

Is Atlanpole Biotherapies a public or private company?

Atlanpole Biotherapies is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Atlanpole Biotherapies founded?

Atlanpole Biotherapies was founded in 2005. It employs 11 to 50 people.

Where is Atlanpole Biotherapies based?

Atlanpole Biotherapies is headquartered in Saint-germain-de-la-grange, France, in the Europe region.

How does Atlanpole Biotherapies make money?

One revenue line is on record: cluster membership services.

Who are Atlanpole Biotherapies's main competitors?

Others on record are Council of European Bioregions (CEBR) and Atlanpole Entreprises. Direct peers are BioWin, Eurobiomed, Lyonbiopôle, BioM, Life Science Krakow Cluster and Biotech Santé Bretagne. Inserm Transfert is listed as an emerging player. Medicen Paris Region is listed as a broad incumbent.

Does Atlanpole Biotherapies have an API?

No public API is recorded for Atlanpole Biotherapies.

What industry is Atlanpole Biotherapies in?

Atlanpole Biotherapies's product category is Biotechnology Cluster Services. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations, with a secondary code of EUAIANAH, Circularity Consulting & Program Management (EPR, Design-for-Circularity, LCA). Its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales